Global Mental Health Summit
Program
Agenda for the Private Public Sector Roundtable
Thursday December 11th Evening Reception
Friday, December 12th, 2025
New York Academy of Medicine
103rd St & 5th Avenue, New York City
GLOBAL MENTAL HEALTH SUMMIT THE AMERICAN IBOGAINE INITIATIVE: A BIPARTISAN IBOGAINE RESEARCH BILL 2026 - SIGN THE PETITION
The Knowledge Recovery Foundation/ Institute (KRFI), a Public Benefit Corporation, a 501(c)(3) nonprofit research and clinical development organization, today announced the American Ibogaine Initiative: A Bipartisan Call to NYS Ibogaine Research Bill for Governor Hochul's sign off during the January General Senate Assembly in NYS, Albany. KRFI is conducting a two-day Global Drug Policy for Mental Health and KRFI Gala Award Dinner fundraising event at the New York Academy of Medicine on December 11–12, 2025. The December 12th event will launch the Global Mental Health Security Fund’s matching allocation to $300 million for other opioid FDA Clinical Trial Grant funding by signing off on the NYS Bipartisan Ibogaine Research grant, supporting the nation’s first-ever FDA clinical trial for ibogaine in the treatment of Opioid Use Disorder (OUD) / Substance. Use Disorder, TBI, Parkinson's Diseases.
This historic Ibogaine research bill initiative unites state leadership, federal regulators, scientific researchers, and global public–private partners to advance safe, ethical, and science-based clinical access to ibogaine, a plant-derived compound showing potential to transform addiction treatment and mental health care.
Global Mental Health Summit Program Overview
Title: The American Ibogaine Initiative: A Bipartisan Call to Healing “Ibogaine Research Act”
Dates: December 11–12, 2025
Venue: The New York Academy of Sciences, 103rd St & 5th Ave, NYC
Hosted by: Knowledge Recovery Foundation Institute (KRFI) in Private Public Sector Partnership with the Global Mental Health Security Fund
The program will feature a Mental Health Policy & Science Roundtable on Thursday, December 11th, 2025
launched with Corporate Breakfast at 8 am and Keynote Speaker in the 1st Floor Presidential Hall
Feature Documentary film screening of “Ibogaine Story: Of Night and Light" Directed by Lucy Walker, 6-8 PM in the
and a guest invited to a cocktail reception at the New York Academy of Medicine for screening at 6-8 and 8-9 pm.
Speakers invited are Governor Kathy Hochul, Attorney General Letitia James, Bryan Hubbard, Director of Americans for Ibogaine, James Hunt,
Former DEA chief, and other UN Missions and Ambassadors for the Ibogaine PPP ABS-IP with UNCED agreements.
A Turning Point in Ibogaine Addiction Research and Global Mental Health Policy
The initiative represents a bipartisan breakthrough in U.S. mental health policy, connecting New York State and Texas through a unified clinical research consortium and establishing an international Access and Benefit-Sharing (ABS) framework for sustainable ibogaine production in Brazil, Gabon, Ghana, Cameroon, DRC, and Costa Rica and others.
The event’s proceeds will fund KRFI’s Contract Research Organization (CRO) and Clinical Trial Management System (CTMS) platform, supporting the FDA Investigational New Drug (IND) application for ibogaine and accelerating cross-border data integration for clinical, regulatory, and environmental traceability.
“This initiative positions New York as a leader in advancing science-based solutions to the opioid crisis. By supporting research, transparency, and cross-sector collaboration, we can open new pathways to recovery for thousands of families.”
Governor Kathy Hochul
Questors: Global Mental Health Private Public Sector Partnership Consortium
The Global Mental Health Security Fund (GMHSF) will match the NYS Ibogaine research bill with private matching investment/contributions to fund the FDA clinical trial through 2026. KRFI Questors CTMS & Reporting Hyperledger, with DSCS blockchain infrastructure, to provide National regulatory compliance, supply chain traceability, and global clinical trial harmonization with partners in Europe, Australia, and Latin America, including MHRA (UK Atai Ibogaine for OUD), ANVISA (AUD Study by PhytoStan - Brazil), and completed studies by ICEERS (Methadone study for Spain).
December 11th, Thursday Hosack Hall (Auditorium 1st Floor)
Opening Remarks and Keynote Speaker
-
8:00 AM Private Public Sector Corporate Breakfast at Presidential Hall, 1st Floor, Global Mental Health Security Partnership investment meeting
-
9:00-10:30 AM Moderated by W. Bryan Hubbard, Mental Health Security Fund and Ibogaine Consortium (TBA) Creating a Private Public Sector Partnership in Ibogaine Clinical Research in NYS, TX, and USA – Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing Moderated by Bryant Hubbard, Ibogaine for Americans
-
10:00 AM - 12:00 PM Keynote speaker and Panel Discussion Moderated with policy view with Rick Perry, Former Governor of Texas, NYS Commissioner Sullivan, of Mental Health, Natalie Rodriguez, and Linda Rosenthal, NYS Senate, are the invitees.
Afternoon Event Highlights
Lunch on Main Floor Reception Hall (Presidential Hall 1st Floor) 12:00 3rd Floor
-
1:00–2:30 PM: Moderated by MyungHi S. Lee. Global alliance on FDA/MHRA/EMEA/ANIVSA registered Clinical Trial Reporting and collaboration for ABS-IP, DSCS Hyperledger, as a dashboard for NYS OASIS Ibogaine Research Bill.
-
Global Clinical Research Alliance Atai in the UK, MHRA for Ibogaine, Norwegian CTA, CU Medical School with IboOxy, Gilgamesh, Hakim Djaballah, Ph.D, GCET LLC. / Bruno Rasmussen, M.D., ANIVSA (AUD) Phystan Brazil, National Consortium for Ibogaine KRFI Clinical Research PPP Speakers, Leading Private Public Sector Partnership Ibogaine for Psychedelic and Progress of funding Norwegian EMEA Ibogaine CT, Clear Sky Canadian Ibogaine Clinical Trial, ICEER clinical trial reporting alliance with UCLA Psychedelic Medical Trial network reporting.
-
2:30 - 4:00 PM Moderated by Andrew Romero, GT Securities, Global Mental Health Security Fund: Roundtable Investment for Ibogaine and Psychedelics. (TBA)
-
4:00 - 5:00 PM Director of Leaf Coalition (TBA) for Biodiversity and Carbon Credit Technologies for the PPP for Indigenous Entheogens Agricultural Programs and Biodiversity & Carbon Credit protocols for US and Emerging Market Private Public Sector Partnerships. Panel to be announced.
-
5:00 - 6:00 PM Future Impact of Synthetic Ibogaine and ABS IP. Panel to be announced, Moderated by Alice Hoot JD (TBA), Chacuna Indigenous IP Leaders for Central America: Costa Rica and KRIBB Extractive Library and the ABS-IP for Genomics and Chemical Library Data Silos for ABS-IP registrations.
December 11th, Thursday, 2nd Floor Hall 21 for breakout Workshop 1 for the joint sessions
-
Workshop 1: 11:00 –12:30 pm: – Moderated by Joanne Morne, Commissioner of NYS Human Rights (TBA) and Commissioner Sullivan, Mental Health (TBA)
-
Workshop 2 1:00-2:30 PM Workshop 1 breakout 2nd Floor Room 21 Moderated by W. Bryan Hubbard, Mental Health Security Fund and Ibogaine Consortium (TBA) Creating a Private Public Sector Partnership in Ibogaine Clinical Research in NYS, TX, and USA – Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing Moderated by Bryant Hubbard, Ibogaine for Americans
-
Workshop 3: 2:30 - 5:00 pm Consortium Structure for Bipartisan Ibogaine Research Act & Policy Roundtable with Dr. Chinazo Cunningham of the Commission (TBA), Reporting on the Bipartisan Bill with potential matching fund by Global Mental Health Security Fund for the “Ibogaine Research Act” to match Texas in 300 Mn for the OUD/SUD
-
6:00–7:30 PM: Cocktail Reception with invited Speakers and Guests
Friday, December 12th, 2025 Hosack Auditorium 1st Floor
-
Corporate Breakfast presentation on 1st Floor, Presidential Reception Hall
-
9:00-10:00 AM Key Note Speaker NYC Mayor Zohran Mandami (TBA) Creating a Private Public Sector Partnership with Youth and Education for the War on Drugs, Protecting our Youth. Moderated by MyungHi S. Lee Q&A with NYC Mayor
-
10:30 Am – 12:00 pm. Private Sector Partnership meeting for the Clinical Trial Alliance. Moderated by New York State Health Commissioner is Dr. James V. McDonald, M.D., M.P.H., moderated by Julie Holland, MD. (TBA): Columbia University OxyIbo, Abbie Pharma/Gilgamesh; Atai OUD products, Ibogaine Consortium, and Global alliance FDA/MHRA/EMEA/ANIVSA registered NYS PPP Dashboard for Clinical Trial Management Reporting and Pharmacovigilance (PV) reporting
12:00 PM Lunch on Main Floor, Presidential Hall (Workshop 1 Hall)
-
1:00-2:30 PM Private Sector Partnership meeting for Access for Benefit Sharing-IP.
-
Moderated by Alex Soros, OSF (TBA), Tropical Nations and Ibogaine ABS-IP for the Private Public Sector Partnership in-country partnership workshop:
-
2:30 -4:00 PM Drug Supply Chain Security Hyperledger, Roundtable for Implementation NYS OASAS, Former DEA Chief, James Hunt, for the implementation of the “Drug Supply Chain Security Act” and State-level dashboard integration as in state-led bipartisan ibogaine research bill for the FDA Clinical Trial of Ibogaine, Opioid/Substance use disorder. The Drug Supply Chain Security Hyperledger aims to safeguard Opioid Synthetic Drugs for compliance with local tracing and tracking.
-
4:00:5:30 PM Moderated by Commissioner Joanne Morne for Human Rights (TBA)
-
Health Equity and Human Rights in State-operated PPP for Ibogaine for Veterans and Indigenous Tribal Access.
Theme: Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing
Worshop Breakout in 2nd Floor Room 21
-
Workshop 1 9:00 - 10:30 AM Workshop Breakout on COP 30 Update and PPP for Access for Benefit Sharing Workshop Theme: Brazilian UN Mission (TBA) Access for Biodiversity Private Public Sector Partnership for Ambassador, UN Mission for Brazil on the Ibogaine production for the NYS partnership for American Ibogaine Initiative; Brazilian Leadership for the Ibogaine and Psychedelic (Ayahuasca) Production for the ANVISA Clinical Trial with Drug Supply Chain Security Hyperledger by the Ministry of Health, Agriculture, and Forestry, Finance. Production of local South American Cultivar Theme on UN Convention on Biodiversity (Access for Benefit Sharing-IP through the indigenous tribal leadership Royalty Based Operation: KRFI’s economist works to build partnership in the access for benefit sharing of IP through royalties of 1% to the Private Public Sector Partnership Program for Countries observing the global Partnership and the Knowledge Recovery Fund International Technical Team for the Corporate offset protocol and technology exploration.
-
Workshop 2 10:00 - 12:00 PM: Panel Speakers: Psychedelics VC, Home Office and PPM, Securities and IPs. (TBA) Moderated by Margret Luge, Psychedelics Insight Moderator of 2025-2030, Prospective Mental Health product development investment, Ibogaine & Psychedelics Portfolios. Panel Speakers: Psychedelics VC, Home Office, and PPM, Securities, and IPs. (TBA)
Lunch on 3rd Floor Reception Hall (Workshop 1 Hall) 12 noon
-
Workshop 3 1:00–2:30 PM: PPP Round Table Global Clinical Research Alliance in NYS consortium and Questors: Open Clinical Trial Management Platform & Reporting Reporting on Private Public Sector Partnership Panel Discussion: for Ambassador of UN Mission, Anivsa AUD Clinical Trials in Brazil, Bruno Ramussen, Phytostan Brazil, and NGO for Indigenous agricultural partnership for ABS-IP model, Natura Cosmetic - Brazilian Model for Ibogaine. RT Panel Discussion with PPP with CU IboOxy team leader/ Abbie /Gilgamesh, Atai Life Science/Srinivas Rao, CEO, KRFI (CRO) MyungHi S. Lee; (TBA)
-
Workshop 4 2:30 – 4:00 PM UN CBD, Carbon + Biodiversity Credit data tokenization for Offset ABS-IP RT Panel Discussion: West African ABS-IP Response by UN Mission and Ambassador of Democratic Republic of Congo, Gabon, Ghana, Cameroon on the Ibogaine production for the NYS partnership for American Ibogaine Initiative;
GALA Award Dinner
(December 12, NY Academy of Sciences)
-
6:00–7:00 PM: Cocktail Reception with invited Speakers and Guests
-
7:00 - 9:30 PM Gala Award Ceremony Dinner
-
Honoring George Soros for the Questors Humanitarian Lifetime Achievement Award
-
Honoring Attorney General Leticia James for the Opioid Settlement Fund and its 20-year outlook from NYS Leadership
“Addressing addiction requires both courage and innovation. The Ibogaine Initiative unites justice reform and medical science under one shared goal: saving lives.”
Attorney General Letitia James
Film Screening (December 11, NY Academy of Sciences)
Evening 1 – Dec 11: “The Story of Ibogaine: Of Night and Light”
-
6:00 - 8:00 PM – Pre-Film Screening: Premiere of the PSA “A Path Home Visual installations: “From Root to Remedy” (interactive ibogaine history, tribal partnerships, neuroscience visualizations).
-
Opening of Lucy Walker’s Documentary Film on "Story of Ibogaine: Of Light and Light”
-
EXCLUSIVE: Lucy Walker, the British filmmaker behind Oscar-nominated docs Waste Land and The Tsunami and the Cherry Blossom, has lined up her latest feature doc.
-
Walker is directing Of Night and Light: The Story of Iboga and Ibogaine, and the film has landed a secret slot at the Tribeca Film Festival.
-
Of Night and Light: The Story of Iboga and Ibogaine tells the astounding, unknown story of what might be the aha scientific breakthrough moment of our generation.
-
Back in 1962, a teenage psychonaut in New York City named Howard Lotsof experimented with an obscure psychedelic from the root bark of a West African shrub and recognized its unique therapeutic potential. Together with his African-American wife Norma, a pair of outsider NYU film students, they dedicated their lives to getting science and government to research it, convinced that it would be of great medicinal benefit, despite it sounding too good to be true, like the very definition of snake oil, and being written off as con artists.
GALA Award Dinner &
Film Screening
(December 12, NY Academy of Sciences)
Evening 2 – Dec 12: “The Story of Ibogaine: Of Night and Light”
-
4:00 - 6:00 PM – Pre-Film Screening: Premiere of the PSA “A Path Home Visual installations: “From Root to Remedy” (interactive ibogaine history, tribal partnerships, neuroscience visualizations). Opening Documentary Film on "Story of Ibogaine: Of Light and Light”
-
8:00 - 9:30 PM – Cocktail Reception (2nd Floor)
-
EXCLUSIVE: Lucy Walker, the British filmmaker behind Oscar-nominated docs Waste Land and The Tsunami and the Cherry Blossom, has lined up her latest feature doc.
-
Walker is directing Of Night and Light: The Story of Iboga and Ibogaine, and the film has landed a secret slot at the Tribeca Film Festival.
-
Of Night and Light: The Story of Iboga and Ibogaine tells the astounding, unknown story of what might be the aha scientific breakthrough moment of our generation.
-
Back in 1962, a teenage psychonaut in New York City named Howard Lotsof experimented with an obscure psychedelic from the root bark of a West African shrub and recognized its unique therapeutic potential. Together with his African-American wife Norma, a pair of outsider NYU film students, they dedicated their lives to getting science and government to research it, convinced that it would be of great medicinal benefit, despite it sounding too good to be true, like the very definition of snake oil, and being written off as con artists.
“The Future of Mental Health Security and Care”
-
6:00 PM – Cocktail Reception (2nd Floor)
-
7:00 PM – Dinner & Pledge Appeal
“Bridging Science and Sovereignty” Tiona Lowdog, M.D., Onandaga Tribal Opioid Response leader
Speakers: Veterans, Tribal Leaders, Scientists, moderated by a celebrity guest.
-
8:00 PM – Musical/Spoken Word Segment:
“Voices of the Earth” – collaboration with Native and veteran performers.
-
9:00 PM Celebrity Guest introduces the “Veterans-to-Healers” scholarship fund.
-
9:30 PM – Closing Remarks (Celebrity TBA):
“Legacy is not in words, but in the lives we help rebuild.”
-
9:30 PM – Live Appeal & Auction:
Hosted by a Celebrity announcement; proceeds directed to the future vision of field clinics, ABS-IP fund, and veterans’ programs.
Sponsorship and Attendance
Table Sponsorships: $25,000 Silver, $50,000 Gold Sponsor; Platinum Sponsor: $100,000
Individual Tickets: $250 individual members, $500 Partnering members, $2,500 Corporate members;
All contributions are tax-deductible and support the KRFI “Ibogaine Research Act” in Consortium successes of the KRFI Questors FDA Clinical Trial Initiative and the Global Mental Health Security Fund.
RSVP by: November 20, 2025
📧 events@krfi.org/Register 🌐 www.krfi.org/donate
“Nations that conscript policies of guns and drugs as personal protection weaponize their own youth. The war against addiction begins with peace in the human mind.”
MyungHi Sonserai Lee, DAOM,
Founder, Knowledge Recovery Foundation/Institute
About the Knowledge Recovery Institute (KRFI)
The Knowledge Recovery Institute (KRFI) is a 501c3 nonprofit scientific organization dedicated to advancing Drug Policy and Drug Research for neglected diseases, including Ibogaine and psychedelic medicine, and in bringing indigenous knowledge of natural products through FDA-regulated clinical research. KRFI’s Questors: AI-driven hyperledger-based clinical trial management, Hyperledger and Tokination of Data Silos for the Biodiversity and Carbon credit-driven protocols, in the private-public partnerships for the Global Mental Health Task Force. KRFI serves as the Contract Research Organization (CRO) for the American Ibogaine Initiative, with Global Ibogaine Therapeutics Alliance through Original Manhattan Project, developing ethical access, supply chain transparency, and clinical validation of ibogaine-based therapies.
About the Global Mental Health Security Fund (GMHSF)
The Global Mental Health Security Fund mobilizes philanthropic and public-sector investment into scalable, data-driven solutions for addiction, trauma, and mental health innovations and technologies. Through matching funds and impact infrastructure, GMHSF supports clinical trials, global regulatory alignment, and biodiversity-driven ABS/IP security and Drug Supply Chain Security Hyperledger.
Media Contact
Press Inquiries:
📩 media@krfi.org | 📞 (212) 722 3960
Press Kit: www.krfi.org/press
Event Media Access Request: www.krfi.org/ibogaineinitiative
Honorary Chairman
George Soros, OSF Chairman/Alex Soros, OSFPresident
Attorney General Leticia James
James Hunt, Former DEA Chief
KRFI NYS Mental Health Security Task Force: Ibogaine Research Act Committee
Brian Kolodny, JPMorgan Chase
Andrew Romero, Managing Director, Global Mental Health Security Fund
Terrance Keeley, ESG Evaluation Lab
Drug Policy and Ibogaine Research Act Tx, Az, OH, NYS
Brian Hubbard, JD, Americans for Ibogaine.org
MyungHI Sonserai Lee DAOM, KRFI Questors for Ibogaine ABS-IP
Alison Hoot JD, Chacuna for Indigenous ABS-IIP
Lisa Gora, JD, NJ Psilocybin Bill Legislature
Program Committee Officers:
Petition Leader: Marcelo Maia, Act UP, NYC,
Media Director: Paul Sladkus, PauseforWorldPeace.org
Andreas Cordova, Investment Relations Outreach
Media Presenter: Aron Ranen
Global Ibogaine for Research Act: A Consortium for Private Public Sector Partnership
American for Ibogaine
Knowledge Recovery Institute
Global Ibogaine Therapist Alliance (GITA) - NYS
Association for Prescriptive Psychedelics
Open Society Foundation
Corporate Sponsor
Psychedelic initiative
Psychedelic Association
American Botanical Association
Sponsored by
NYS HHS, NYS Commission for Human Rights, and OASAS,
UNCBD, WHO, UNEP